Abiomed (ABMD)

222.32 +1.37 (0.62%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (1/31/20 *Est.)

Latest Headlines

Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock November 14, 2019 9:59 AM - BizWire ABIOMED (ABMD) PT Raised to $240 at SVB Leerink November 1, 2019 9:34 AM - StreetInsider Form 10-Q ABIOMED INC For: Sep 30 October 31, 2019 4:14 PM - SEC Filing Form 8-K ABIOMED INC For: Oct 31 October 31, 2019 7:15 AM - SEC Filing Abiomed (ABMD) Posts Q2 GAAP EPS of $0.28 October 31, 2019 7:07 AM - StreetInsider First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump October 31, 2019 7:02 AM - BizWire Abiomed Announces Q2 FY 2020 Revenue of $205 Million and 29.4% Operating Margin October 31, 2019 7:00 AM - BizWire Raymond James Downgrades ABIOMED (ABMD) to Market Perform October 29, 2019 6:21 AM - StreetInsider CORRECTING and REPLACING CAPTION FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival October 26, 2019 9:15 AM - BizWire FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival October 25, 2019 8:00 AM - BizWire Piper Jaffray Highlights ABIOMED (ABMD) Related to Competitor Trial Changes October 23, 2019 11:27 AM - StreetInsider Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification October 10, 2019 3:55 PM - BizWire Abiomed Announces 1,000th Patient Treated with Impella in Japan October 7, 2019 8:00 AM - BizWire Form 4 ABIOMED INC For: Sep 30 Filed by: Howley Michael G October 2, 2019 4:26 PM - SEC Filing Form 4 ABIOMED INC For: Sep 30 Filed by: MINOGUE MICHAEL R October 2, 2019 4:26 PM - SEC Filing Form 4 ABIOMED INC For: Sep 30 Filed by: Greenfield Andrew J October 2, 2019 4:25 PM - SEC Filing Abiomed (ABMD) Says Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock September 27, 2019 8:08 AM - StreetInsider Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock; Escalation Protocols Initiated September 27, 2019 8:05 AM - BizWire PROTECT III Presented at TCT 2019 – Clinical Data Demonstrates Protected PCI with Impella is Associated with Improved Outcomes September 26, 2019 10:30 AM - BizWire Abiomed (ABMD) Receives FDA PMA Approval for Impella 5.5 with SmartAssist September 25, 2019 7:07 AM - StreetInsider Abiomed Receives FDA PMA Approval for Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump September 25, 2019 7:05 AM - BizWire Abiomed (ABMD) Announces Highest Court in Germany Affirms Strength of its Patents September 23, 2019 8:55 AM - StreetInsider Highest Court in Germany Affirms Strength of Abiomed’s Patents September 23, 2019 8:55 AM - BizWire Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019 September 17, 2019 8:35 AM - BizWire Abiomed to Present at the Morgan Stanley Global Healthcare Conference September 3, 2019 7:00 AM - BizWire Impella® SmartAssist Platform Launches at ESC, Designed to Further Improve Patient Outcomes August 31, 2019 3:05 AM - BizWire Full Article List